Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000932 | P-body | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0030015 | CCR4-NOT core complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 11 |
GO:0035770 | ribonucleoprotein granule | 3 | 2 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0099080 | supramolecular complex | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0140535 | intracellular protein-containing complex | 2 | 11 |
GO:0030014 | CCR4-NOT complex | 3 | 9 |
GO:0016020 | membrane | 2 | 2 |
Related structures:
AlphaFold database: Q4Q286
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006401 | RNA catabolic process | 5 | 11 |
GO:0006402 | mRNA catabolic process | 6 | 11 |
GO:0006417 | regulation of translation | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009056 | catabolic process | 2 | 11 |
GO:0009057 | macromolecule catabolic process | 4 | 11 |
GO:0009889 | regulation of biosynthetic process | 4 | 2 |
GO:0009890 | negative regulation of biosynthetic process | 5 | 2 |
GO:0009892 | negative regulation of metabolic process | 4 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0010468 | regulation of gene expression | 5 | 11 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 2 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 6 | 2 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 11 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 2 |
GO:0010629 | negative regulation of gene expression | 6 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0016071 | mRNA metabolic process | 6 | 11 |
GO:0017148 | negative regulation of translation | 7 | 2 |
GO:0019222 | regulation of metabolic process | 3 | 11 |
GO:0019439 | aromatic compound catabolic process | 4 | 11 |
GO:0031323 | regulation of cellular metabolic process | 4 | 2 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 2 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 2 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6 | 2 |
GO:0034248 | regulation of amide metabolic process | 5 | 2 |
GO:0034249 | negative regulation of amide metabolic process | 6 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044248 | cellular catabolic process | 3 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 11 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0046700 | heterocycle catabolic process | 4 | 11 |
GO:0048519 | negative regulation of biological process | 3 | 11 |
GO:0048523 | negative regulation of cellular process | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 11 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 2 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 2 |
GO:0051246 | regulation of protein metabolic process | 5 | 2 |
GO:0051248 | negative regulation of protein metabolic process | 6 | 2 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0080090 | regulation of primary metabolic process | 4 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 11 |
GO:1901575 | organic substance catabolic process | 3 | 11 |
GO:2000112 | obsolete regulation of cellular macromolecule biosynthetic process | 6 | 2 |
GO:2000113 | obsolete negative regulation of cellular macromolecule biosynthetic process | 7 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 144 | 150 | PF00089 | 0.523 |
CLV_NRD_NRD_1 | 165 | 167 | PF00675 | 0.464 |
CLV_NRD_NRD_1 | 333 | 335 | PF00675 | 0.537 |
CLV_NRD_NRD_1 | 350 | 352 | PF00675 | 0.515 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.348 |
CLV_PCSK_KEX2_1 | 165 | 167 | PF00082 | 0.523 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.650 |
CLV_PCSK_PC1ET2_1 | 101 | 103 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 288 | 292 | PF00082 | 0.530 |
CLV_PCSK_SKI1_1 | 307 | 311 | PF00082 | 0.368 |
CLV_PCSK_SKI1_1 | 335 | 339 | PF00082 | 0.493 |
CLV_PCSK_SKI1_1 | 76 | 80 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.226 |
CLV_Separin_Metazoa | 190 | 194 | PF03568 | 0.348 |
DEG_APCC_DBOX_1 | 306 | 314 | PF00400 | 0.348 |
DEG_APCC_DBOX_1 | 333 | 341 | PF00400 | 0.324 |
DEG_APCC_DBOX_1 | 75 | 83 | PF00400 | 0.562 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.785 |
DOC_CDC14_PxL_1 | 175 | 183 | PF14671 | 0.273 |
DOC_CKS1_1 | 133 | 138 | PF01111 | 0.303 |
DOC_MAPK_FxFP_2 | 176 | 179 | PF00069 | 0.273 |
DOC_MAPK_gen_1 | 334 | 342 | PF00069 | 0.273 |
DOC_MAPK_gen_1 | 91 | 98 | PF00069 | 0.495 |
DOC_MAPK_MEF2A_6 | 334 | 342 | PF00069 | 0.263 |
DOC_MAPK_NFAT4_5 | 335 | 343 | PF00069 | 0.273 |
DOC_PP4_FxxP_1 | 176 | 179 | PF00568 | 0.273 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.347 |
DOC_USP7_MATH_2 | 9 | 15 | PF00917 | 0.728 |
DOC_USP7_UBL2_3 | 100 | 104 | PF12436 | 0.523 |
DOC_WW_Pin1_4 | 132 | 137 | PF00397 | 0.287 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.348 |
LIG_14-3-3_CanoR_1 | 147 | 152 | PF00244 | 0.303 |
LIG_14-3-3_CanoR_1 | 193 | 198 | PF00244 | 0.270 |
LIG_14-3-3_CanoR_1 | 262 | 270 | PF00244 | 0.286 |
LIG_14-3-3_CanoR_1 | 319 | 324 | PF00244 | 0.323 |
LIG_14-3-3_CanoR_1 | 93 | 99 | PF00244 | 0.567 |
LIG_Actin_WH2_2 | 286 | 301 | PF00022 | 0.262 |
LIG_CtBP_PxDLS_1 | 315 | 319 | PF00389 | 0.323 |
LIG_EH1_1 | 240 | 248 | PF00400 | 0.262 |
LIG_FHA_1 | 238 | 244 | PF00498 | 0.262 |
LIG_FHA_2 | 182 | 188 | PF00498 | 0.348 |
LIG_FHA_2 | 320 | 326 | PF00498 | 0.367 |
LIG_LIR_Gen_1 | 103 | 112 | PF02991 | 0.487 |
LIG_LIR_Gen_1 | 261 | 270 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 103 | 108 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 111 | 116 | PF02991 | 0.314 |
LIG_LIR_Nem_3 | 128 | 133 | PF02991 | 0.171 |
LIG_LIR_Nem_3 | 261 | 266 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 322 | 326 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 69 | 74 | PF02991 | 0.641 |
LIG_LYPXL_S_1 | 129 | 133 | PF13949 | 0.462 |
LIG_LYPXL_S_1 | 177 | 181 | PF13949 | 0.462 |
LIG_LYPXL_yS_3 | 130 | 133 | PF13949 | 0.262 |
LIG_LYPXL_yS_3 | 178 | 181 | PF13949 | 0.262 |
LIG_LYPXL_yS_3 | 71 | 74 | PF13949 | 0.629 |
LIG_NRBOX | 336 | 342 | PF00104 | 0.262 |
LIG_Pex14_2 | 176 | 180 | PF04695 | 0.273 |
LIG_PTB_Apo_2 | 317 | 324 | PF02174 | 0.273 |
LIG_SH2_STAT3 | 22 | 25 | PF00017 | 0.788 |
LIG_SH2_STAT3 | 255 | 258 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.262 |
LIG_SH2_STAT5 | 297 | 300 | PF00017 | 0.283 |
LIG_SH2_STAT5 | 326 | 329 | PF00017 | 0.348 |
LIG_SH3_3 | 137 | 143 | PF00018 | 0.348 |
LIG_SH3_3 | 281 | 287 | PF00018 | 0.367 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.742 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.747 |
LIG_SH3_3 | 49 | 55 | PF00018 | 0.676 |
LIG_SUMO_SIM_anti_2 | 149 | 156 | PF11976 | 0.274 |
LIG_SUMO_SIM_par_1 | 94 | 99 | PF11976 | 0.544 |
LIG_TRAF2_1 | 322 | 325 | PF00917 | 0.367 |
LIG_TRAF2_1 | 9 | 12 | PF00917 | 0.788 |
LIG_TRAF2_2 | 68 | 73 | PF00917 | 0.660 |
LIG_UBA3_1 | 220 | 226 | PF00899 | 0.303 |
LIG_UBA3_1 | 95 | 101 | PF00899 | 0.532 |
LIG_WRC_WIRS_1 | 238 | 243 | PF05994 | 0.262 |
MOD_CDK_SPxxK_3 | 181 | 188 | PF00069 | 0.348 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.290 |
MOD_CK1_1 | 261 | 267 | PF00069 | 0.367 |
MOD_CK2_1 | 181 | 187 | PF00069 | 0.341 |
MOD_CK2_1 | 298 | 304 | PF00069 | 0.348 |
MOD_CK2_1 | 319 | 325 | PF00069 | 0.367 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.548 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.435 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.277 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.327 |
MOD_N-GLC_1 | 319 | 324 | PF02516 | 0.487 |
MOD_N-GLC_2 | 172 | 174 | PF02516 | 0.548 |
MOD_NEK2_1 | 112 | 117 | PF00069 | 0.231 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.305 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.275 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.506 |
MOD_PIKK_1 | 66 | 72 | PF00454 | 0.648 |
MOD_PK_1 | 147 | 153 | PF00069 | 0.287 |
MOD_PKA_1 | 350 | 356 | PF00069 | 0.429 |
MOD_PKA_2 | 146 | 152 | PF00069 | 0.287 |
MOD_PKA_2 | 192 | 198 | PF00069 | 0.278 |
MOD_PKA_2 | 261 | 267 | PF00069 | 0.287 |
MOD_PKA_2 | 298 | 304 | PF00069 | 0.262 |
MOD_PKA_2 | 350 | 356 | PF00069 | 0.429 |
MOD_Plk_1 | 319 | 325 | PF00069 | 0.303 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.429 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.330 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.273 |
MOD_Plk_4 | 237 | 243 | PF00069 | 0.256 |
MOD_ProDKin_1 | 132 | 138 | PF00069 | 0.287 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.348 |
TRG_DiLeu_BaEn_1 | 103 | 108 | PF01217 | 0.548 |
TRG_DiLeu_BaEn_4 | 12 | 18 | PF01217 | 0.612 |
TRG_DiLeu_BaLyEn_6 | 128 | 133 | PF01217 | 0.262 |
TRG_DiLeu_BaLyEn_6 | 285 | 290 | PF01217 | 0.262 |
TRG_ENDOCYTIC_2 | 130 | 133 | PF00928 | 0.262 |
TRG_ENDOCYTIC_2 | 178 | 181 | PF00928 | 0.262 |
TRG_ENDOCYTIC_2 | 297 | 300 | PF00928 | 0.273 |
TRG_ENDOCYTIC_2 | 32 | 35 | PF00928 | 0.766 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.631 |
TRG_ER_diArg_1 | 165 | 167 | PF00400 | 0.323 |
TRG_ER_diArg_1 | 350 | 352 | PF00400 | 0.450 |
TRG_NES_CRM1_1 | 233 | 244 | PF08389 | 0.287 |
TRG_Pf-PMV_PEXEL_1 | 312 | 316 | PF00026 | 0.487 |
TRG_Pf-PMV_PEXEL_1 | 350 | 354 | PF00026 | 0.611 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1Y3 | Leptomonas seymouri | 92% | 100% |
A0A0S4ITM9 | Bodo saltans | 57% | 100% |
A0A1X0PA96 | Trypanosomatidae | 55% | 100% |
A0A3R7N5E2 | Trypanosoma rangeli | 52% | 100% |
A0A3S7X8L0 | Leishmania donovani | 98% | 100% |
A4HBG1 | Leishmania braziliensis | 94% | 100% |
A4IAK7 | Leishmania infantum | 98% | 100% |
A7MB47 | Bos taurus | 48% | 100% |
C9ZLN4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9B5N2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
P53829 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 47% | 97% |
Q4R347 | Macaca fascicularis | 48% | 100% |
Q5PQL2 | Rattus norvegicus | 48% | 100% |
Q5R6Z6 | Pongo abelii | 48% | 100% |
Q6IP65 | Xenopus laevis | 48% | 100% |
Q6NWL4 | Danio rerio | 50% | 100% |
Q6P819 | Xenopus tropicalis | 48% | 100% |
Q92368 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 50% | 100% |
Q92600 | Homo sapiens | 48% | 100% |
Q9JKY0 | Mus musculus | 48% | 100% |
V5BLQ5 | Trypanosoma cruzi | 54% | 100% |